Prevention of heart failure in treatments with trastuzumab and anthracyclines: a meta-analysis

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Frieder Braunschweig

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail

Effect of calcitriol attenuates doxorubicin-induced cardiac dysfunction in mice model: focus on endothelial-to-mesenchymal transition

Doctor T. Tsai (Kaohsiung, TW)

Presentation thumbnail

New role of EPAC1 in Anthracycline-induced cardiotoxicity and anticancer therapy

Miss A. BELHADEF (Chatenay-Malabry, FR)

Presentation thumbnail

Usefulness of cardiac magnetic resonance imaging for early detection of subclinical chemotherapy-related cardiac dysfunction in cancer patients

Doctor Y. Terui (Sendai, JP)

Abstract Slides

Presentation thumbnail

CMR Fast-SENC intramyocardial LV & RV segmental strain detects cardiotoxicity during oncology treatment and impact of cardioprotection therapy before echocardiography

Doctor M. Montenbruck (Hamburg, DE)

Presentation thumbnail

Malignancy after Heart Transplantation: Difference in incidence and prognosis between genders. Data from the Spanish post-Heart Transplant Tumor Registry.

Doctor C. Minguito Carazo (A Coruna, ES)

Abstract Slides

Access the full session

Session thumbnail

Cardio-Oncology: insights from basic , clinical, data science

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Session

Chronic kidney disease and heart failure

Congress Presentation

Moving beyond diuretics: advances in treatment of cardiomyopathies and heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources